Table 3.
Percentage of multiple hrHPV infection among hrHPV-positive cases within various histological groups.
| Histology | <30 y | 30-49 y | ≥50 y | Total | ||||
|---|---|---|---|---|---|---|---|---|
| hrHPV Positive# | 2≥hrHPV# (%) |
hrHPV Positive# | ≥2 hrHPV# (%) |
hrHPV Positive# | ≥2 hrHPV# (%) |
hrHPV Positive# | ≥2 hrHPV# (%) |
|
| Negative | 3,422 | 1040 (30.4) | 11,040 | 2,412 (21.8) | 5,934 | 1760 (29.7) | 20,396 | 5212 (25.6) |
| CIN1 | 2,174 | 1063 (48.9) | 4,909 | 1,764 (35.9) | 1813 | 845 (46.6) | 8,896 | 3672 (41.3) |
| CIN2/3 | 481 | 191 (39.7) | 2,040 | 634 (31.1) | 981 | 376 (38.3) | 3,502 | 1201 (34.3) |
| SCC | 12 | 2 (16.7) | 269 | 52 (19.3) | 448 | 116 (25.9) | 729 | 170 (23.3) |
| AIS | 5 | 0 (0.0) | 39 | 5 (12.8) | 6 | 0 (0.0) | 50 | 5 (10.0) |
| ADC | 3 | 2 (66.7) | 47 | 12 (25.5) | 28 | 7 (25.0) | 78 | 21 (26.9) |
| AIS+HSIL | 18 | 5 (27.8) | 48 | 12 (25.0) | 14 | 3 (21.4) | 80 | 20 (25.0) |
| ADSQ | 6 | 1 (16.7) | 41 | 3 (7.3) | 48 | 12 (25.0) | 95 | 16 (16.8) |
| SNEC | 2 | 1 (50.0) | 9 | 4 (44.4) | 3 | 0 (0.0) | 14 | 5 (35.7) |
CIN1, cervical intraepithelial neoplasia 1; CIN2/3, cervical intraepithelial neoplasia 2/3; AIS, endocervical adenocarcinoma in situ; SCC, squamous cell carcinoma of cervix, ADC, invasive adenocarcinoma of endocervix; ADSQ, adenosquamous carcinoma of endocervix; SNEC, small cell neuroendocrine carcinoma of endocervix; hrHPV, high-risk human papillomavirus; #, number; y, years.